Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07081217 · ClinicalTrials.gov registry record · Early Phase 1
Radiocaine Safety Study In Healthy Human Subjects
A Early Phase 1 study of Healthy Subjects, sponsored by Lutroo Imaging.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT07081217: Recruiting Early Phase 1 study of Healthy Subjects, sponsored by Lutroo Imaging.
NCT07081217 is a Early Phase 1 study of Healthy Subjects that is actively recruiting participants, run by Lutroo Imaging. The registered enrollment target is 6 participants, below the 129-participant average among 69 other Healthy Subjects trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07081217, a Early Phase 1 study of Healthy Subjects, is actively recruiting participants, sponsored by Lutroo Imaging.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 1, single-center, open-label study evaluating the safety, biodistribution, and radiation dosimetry of Radiocaine™, an investigational fluorine-18-labeled PET radiotracer designed to bind voltage-gated sodium channels in pain-related peripheral nerves. The study will enroll healthy adult volunteers and aims to inform future clinical development in pain imaging. Radiocaine™ is being developed as a potential imaging biomarker for the localization and quantification of pain.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Intravenous Radiocaine
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-06-17 |
| Est. Completion | 2026-04 |
| Phase | Early Phase 1 |
What NCT07081217 shows while recruiting
NCT07081217 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 129-participant average among 69 other Healthy Subjects trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which Intravenous Radiocaine is the first listed.
NCT07081217 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07081217 about?
NCT07081217 is a clinical study titled "Radiocaine Safety Study In Healthy Human Subjects". This is a Phase 1, single-center, open-label study evaluating the safety, biodistribution, and radiation dosimetry of Radiocaine™, an investigational fluorine-18-labeled PET radiotracer designed to bind voltage-gated sodium channels in pain-related peripheral nerves. The study will enroll healthy ad...
What is the current status of trial NCT07081217?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2025-06-17. Estimated completion is 2026-04.
What conditions does trial NCT07081217 study?
This clinical trial studies the following conditions: Healthy Subjects.
What interventions are being tested in trial NCT07081217?
The interventions under investigation include: Intravenous Radiocaine (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07081217?
This trial is sponsored by Lutroo Imaging, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07081217 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07081217's enrollment target sits among peer trials
6 68th of 69 the lowest of 69 other Healthy Subjects trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Subjects trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Single-tracer Multiparametric PET Imaging
RECRUITING · Early Phase 1
-
Methemoglobin Concentration in High Dose Inhaled Nitric Oxide
ACTIVE NOT RECRUITING · Early Phase 1
-
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
RECRUITING
-
Phase I Study of ICP-332 in Healthy Subjects
RECRUITING · Phase 1
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
-
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI